Aristotle Atlantic Partners’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-41,827
| Closed | -$993K | – | 99 |
|
|
2019
Q4 | $993K | Sell |
41,827
-9,316
| -18% | -$221K | 0.13% | 73 |
|
|
2019
Q3 | $1.41M | Sell |
51,143
-40
| -0.1% | -$1.1K | 0.4% | 55 |
|
|
2019
Q2 | $1.69M | Buy |
51,183
+12
| +0% | +$397 | 0.49% | 39 |
|
|
2019
Q1 | $1.79M | Buy |
51,171
+26,989
| +112% | +$946K | 0.54% | 35 |
|
|
2018
Q4 | $803K | Buy |
24,182
+3,432
| +17% | +$114K | 0.28% | 55 |
|
|
2018
Q3 | $1.05M | Hold |
20,750
| – | – | 0.64% | 32 |
|
|
2018
Q2 | $1.24M | Buy |
20,750
+5,750
| +38% | +$344K | 0.43% | 35 |
|
|
2018
Q1 | $687K | Hold |
15,000
| – | – | 0.25% | 43 |
|
|
2017
Q4 | $598K | Buy |
+15,000
| New | +$598K | 0.21% | 42 |
|